Back to ProShare Advisors LLC ProShare Advisors LLC

CRSPCRSP
Showing 7 of 30 quarters

Position history for ProShare Advisors LLCProShare Advisors LLC's holdings in CRISPR THERAPEUTICS AG

ProShare Advisors LLC holds 15,775 shares of CRSP (CRISPR THERAPEUTICS AG), worth $860,368 as of 2026-Q2. The position was decreased (-12.0% shares). CRSP represents 0.0% of ProShare Advisors LLC's portfolio.

Current Value

$860,368

Current Shares

15,775

Total Value Change

+$608,650

Total Shares Change

+10,417

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
15,775
-12.0%
$860,3680.0%$54.54
0
2026-Q1
Decreased
17,927
-12.3%
$852,7880.0%$58.06
0
2025-Q4
Increased
20,447
+14.5%
$1.1M0.0%$53.19
29
2025-Q3
Decreased
17,853
-13.9%
$1.2M0.0%$63.77
0
2025-Q2
New
20,732
-
$1M0.0%$47.49
35
2024-Q4
Exited
0
-100.0%
$00.0%$38.65
0
2024-Q3
Decreased
5,358
-3.8%
$251,7180.0%$47.32
0

Other major holders of CRSP: ARK Investment Management LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used